Cargando…

Structural basis for phospholipase A(2)-like toxin inhibition by the synthetic compound Varespladib (LY315920)

The World Health Organization recently listed snakebite envenoming as a Neglected Tropical Disease, proposing strategies to significantly reduce the global burden of this complex pathology by 2030. In this context, effective adjuvant treatments to complement conventional antivenom therapy based on i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvador, Guilherme H. M., Gomes, Antoniel A. S., Bryan-Quirós, Wendy, Fernández, Julián, Lewin, Matthew R., Gutiérrez, José María, Lomonte, Bruno, Fontes, Marcos R. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868273/ https://www.ncbi.nlm.nih.gov/pubmed/31748642 http://dx.doi.org/10.1038/s41598-019-53755-5

Ejemplares similares

Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms
por: Gutiérrez, José María, et al.
Publicado: (2020)

Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation
por: Lewin, Matthew, et al.
Publicado: (2016)

Action of Varespladib (LY-315920), a Phospholipase A(2) Inhibitor, on the Enzymatic, Coagulant and Haemorrhagic Activities of Lachesis muta rhombeata (South-American Bushmaster) Venom
por: Gutierres, Pamella G., et al.
Publicado: (2022)

Coagulotoxic Cobras: Clinical Implications of Strong Anticoagulant Actions of African Spitting Naja Venoms That Are Not Neutralised by Antivenom but Are by LY315920 (Varespladib)
por: Bittenbinder, Mátyás A., et al.
Publicado: (2018)

Anticoagulant Activity of Naja nigricollis Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
por: Kazandjian, Taline D., et al.
Publicado: (2021)

Delayed LY333013 (Oral) and LY315920 (Intravenous) Reverse Severe Neurotoxicity and Rescue Juvenile Pigs from Lethal Doses of Micrurus fulvius (Eastern Coral Snake) Venom
por: Lewin, Matthew R., et al.
Publicado: (2018)

The BRAVO Clinical Study Protocol: Oral Varespladib for Inhibition of Secretory Phospholipase A2 in the Treatment of Snakebite Envenoming
por: Carter, Rebecca W., et al.
Publicado: (2022)

Varespladib Inhibits the Phospholipase A(2) and Coagulopathic Activities of Venom Components from Hemotoxic Snakes
por: Xie, Chunfang, et al.
Publicado: (2020)

A-002 (Varespladib), a phospholipase A(2 )inhibitor, reduces atherosclerosis in guinea pigs
por: Leite, Jose O, et al.
Publicado: (2009)

Ex Vivo Effect of Varespladib on Secretory Phospholipase A2 Alveolar Activity in Infants with ARDS
por: De Luca, Daniele, et al.
Publicado: (2012)

Search for efficient inhibitors of myotoxic activity induced by ophidian phospholipase A(2)-like proteins using functional, structural and bioinformatics approaches
por: Salvador, Guilherme H. M., et al.
Publicado: (2019)

The allosteric activation mechanism of a phospholipase A(2)-like toxin from Bothrops jararacussu venom: a dynamic description
por: Gomes, Antoniel A. S., et al.
Publicado: (2020)

Delayed Oral LY333013 Rescues Mice from Highly Neurotoxic, Lethal Doses of Papuan Taipan (Oxyuranus scutellatus) Venom
por: Lewin, Matthew R., et al.
Publicado: (2018)

Structural Basis for the Inhibition of a Phospholipase A(2)-Like Toxin by Caffeic and Aristolochic Acids
por: Fernandes, Carlos A. H., et al.
Publicado: (2015)

A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib
por: Arrahman, Arif, et al.
Publicado: (2022)

Exploration of the Inhibitory Potential of Varespladib for Snakebite Envenomation
por: Wang, Yiding, et al.
Publicado: (2018)

Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes
por: Lewin, Matthew R., et al.
Publicado: (2022)

Oral and IV Varespladib Rescue Experiments in Juvenile Pigs with Weakness Induced by Australian and Papuan Oxyuranus scutellatus Venoms
por: Gilliam, Lyndi L., et al.
Publicado: (2023)

In Vitro Efficacy of Antivenom and Varespladib in Neutralising Chinese Russell’s Viper (Daboia siamensis) Venom Toxicity
por: Lay, Mimi, et al.
Publicado: (2023)

Unity Makes Strength: Exploring Intraspecies and Interspecies Toxin Synergism between Phospholipases A(2) and Cytotoxins
por: Pucca, Manuela B., et al.
Publicado: (2020)

PLA(2) Inhibitor Varespladib as an Alternative to the Antivenom Treatment for Bites from Nikolsky’s Viper Vipera berus nikolskii
por: Zinenko, Oleksandr, et al.
Publicado: (2020)

Correction: Wang et al. Exploration of the Inhibitory Potential of Varespladib for Snakebite Envenomation. Molecules 2018, 23, 391
por: Wang, Yiding, et al.
Publicado: (2022)

Inhibitory Effects of Varespladib, CP471474, and Their Potential Synergistic Activity on Bothrops asper and Crotalus durissus cumanensis Venoms
por: Quiroz, Sara, et al.
Publicado: (2022)

Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A(2) from the Central American coral snake, Micrurus nigrocinctus
por: Laustsen, Andreas H., et al.
Publicado: (2017)

Venom of the Coral Snake Micrurus clarki: Proteomic Profile, Toxicity, Immunological Cross-Neutralization, and Characterization of a Three-Finger Toxin
por: Lomonte, Bruno, et al.
Publicado: (2016)

Secreted Phospholipases A(2) from Animal Venoms in Pain and Analgesia
por: Zambelli, Vanessa O., et al.
Publicado: (2017)

Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A(2): activation of endogenous phospholipases contributes to the pronociceptive effect
por: Dias, Renata Gonçalves, et al.
Publicado: (2017)

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome
por: Luo, Linlin, et al.
Publicado: (2016)

Phospholipase A2 inhibitor and LY6/PLAUR domain-containing protein PINLYP regulates type I interferon innate immunity
por: Liu, Zhongshun, et al.
Publicado: (2021)

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
por: Kawai, Takahiro, et al.
Publicado: (2020)

A Lipidomic Perspective of the Action of Group IIA Secreted Phospholipase A(2) on Human Monocytes: Lipid Droplet Biogenesis and Activation of Cytosolic Phospholipase A(2)α
por: Rodríguez, Juan P., et al.
Publicado: (2020)

LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling
por: Matsuda, R, et al.
Publicado: (2011)

Structural and functional characterization of suramin-bound MjTX-I from Bothrops moojeni suggests a particular myotoxic mechanism
por: Salvador, Guilherme H. M., et al.
Publicado: (2018)

Developmental and communicative interrelations of Ly123 and Ly1 cell sets
Publicado: (1980)

Neces-SARI-ly?
por: Martin-Loeches, Ignacio, et al.
Publicado: (2016)

Edema Toxin Impairs Anthracidal Phospholipase A2 Expression by Alveolar Macrophages
por: Raymond, Benoit, et al.
Publicado: (2007)

Evolutionary dynamics of origin and loss in the deep history of phospholipase D toxin genes
por: Cordes, Matthew H. J., et al.
Publicado: (2018)

Expression pattern of three-finger toxin and phospholipase A(2 )genes in the venom glands of two sea snakes, Lapemis curtus and Acalyptophis peronii: comparison of evolution of these toxins in land snakes, sea kraits and sea snakes
por: Pahari, Susanta, et al.
Publicado: (2007)

The Genetic Basis of Toxin Biosynthesis in Dinoflagellates
por: Verma, Arjun, et al.
Publicado: (2019)

A Representative GIIA Phospholipase A(2) Activates Preadipocytes to Produce Inflammatory Mediators Implicated in Obesity Development
por: Leiguez, Elbio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c9ihnsud3eeog6r6asah6mp8n4